Parallel evolution under chemotherapy pressure in 29 breast cancer cell lines results in dissimilar mechanisms of resistance.
<h4>Background</h4>Developing chemotherapy resistant cell lines can help to identify markers of resistance. Instead of using a panel of highly heterogeneous cell lines, we assumed that truly robust and convergent pattern of resistance can be identified in multiple parallel engineered der...
Main Authors: | Bálint Tegze, Zoltán Szállási, Irén Haltrich, Zsófia Pénzváltó, Zsuzsa Tóth, István Likó, Balázs Gyorffy |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22319589/pdf/?tool=EBI |
Similar Items
-
Identifying resistance mechanisms against five tyrosine kinase inhibitors targeting the ERBB/RAS pathway in 45 cancer cell lines.
by: Zsófia Pénzváltó, et al.
Published: (2013-01-01) -
A Network-Based Target Overlap Score for Characterizing Drug Combinations: High Correlation with Cancer Clinical Trial Results.
by: Balázs Ligeti, et al.
Published: (2015-01-01) -
Jetset: selecting the optimal microarray probe set to represent a gene
by: Li Qiyuan, et al.
Published: (2011-12-01) -
Resistance to Combined Anthracycline–Taxane Chemotherapy Is Associated with Altered Metabolism and Inflammation in Breast Carcinomas
by: Otília Menyhárt, et al.
Published: (2024-01-01) -
Are tumor-associated carbohydrates the missing link between the gut microbiome and response to immune checkpoint inhibitor treatment in cancer?
by: Zoltan Szallasi, et al.
Published: (2024-12-01)